A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects
Status:
Completed
Trial end date:
2018-06-21
Target enrollment:
Participant gender:
Summary
This is a randomised, cross-over study comprised of 6 periods in healthy subjects.Subjects
will receive Regimens A, B and C in a randomised crossover manner in the fed state, followed
by Regimens D, E and F in a randomised crossover manner, in the fasted or fed state, as
applicable.